Seasonality of respiratory syncytial virus infection in children hospitalized with acute lower respiratory tract infections in Hunan, China, 2013-2022

• Published in: Virology journal Vol. 21; no. 1; p. 62
• Main Authors: Xie, Le-Yun, Wang, Tao, Yu, Tian, Hu, Xian, Yang, Le, Zhong, Li-Li, Zhang, Bing, Zeng, Sai-Zhen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 07.03.2024; BioMed Central; BMC
• Subjects: Child; Children; China - epidemiology; Congenital diseases; Coronaviruses; COVID-19; COVID-19 - epidemiology; Demographic aspects; Epidemics; Epidemiology; Hospital patients; Humans; Infant; Influenza; Pandemics; Pediatric research; Pediatric respiratory diseases; Public health; Regression analysis; Respiratory syncytial virus; Respiratory syncytial virus infection; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory tract infection; Respiratory Tract Infections; Risk factors; Seasonal variations; Seasonal variations (Diseases); Seasonality; Seasons; Statistics; China; United States > US; COVID-19; Respiratory syncytial virus; Children; Seasonality
• ISSN: 1743-422X; 1743-422X
• DOI: 10.1186/s12985-024-02336-8

In China, respiratory syncytial virus (RSV) infections traditionally occur during the spring and winter seasons. However, a shift in the seasonal trend was noted in 2020-2022, during the coronavirus disease 2019 (COVID-19) pandemic. This study investigated the seasonal characteristics of RSV infection in children hospitalized with acute lower respiratory tract infections (ALRTIs). The RSV epidemic season was defined as RSV positivity in > 10% of the hospitalized ALRTI cases each week. Nine RSV seasons were identified between 2013 and 2022, and nonlinear ordinary least squares regression models were used to assess the differences in year-to-year epidemic seasonality trends. We enrolled 49,658 hospitalized children diagnosed with ALRTIs over a 9-year period, and the RSV antigen-positive rate was 15.2% (n = 7,566/49,658). Between 2013 and 2022, the average onset and end of the RSV season occurred in week 44 (late October) and week 17 of the following year, respectively, with a typical duration of 27 weeks. However, at the onset of the COVID-19 pandemic, the usual spring RSV peak did not occur. Instead, the 2020 epidemic started in week 32, and RSV seasonality persisted into 2021, lasting for an unprecedented 87 weeks before concluding in March 2022. RSV seasonality was disrupted during the COVID-19 pandemic, and the season exhibited an unusually prolonged duration. These findings may provide valuable insights for clinical practice and public health considerations.